Literature DB >> 2666958

The treatment of alcohol withdrawal.

S K Guthrie1.   

Abstract

Abrupt cessation of regular use of alcohol in a dependent person causes a withdrawal syndrome that may range from mild to extremely severe. Most patients require pharmacologic intervention, especially those with severe symptoms. Historically, the pharmacotherapy of alcohol withdrawal has involved a wide variety of agents. Benzodiazepines are currently preferred due to their consistently high degree of efficacy and laudable record of safety. In addition, beta blockers and clonidine are useful, as both effectively combat the hypertension and tachycardia commonly associated with withdrawal. They are ineffective as anticonvulsants; however. Opinions differ concerning the best treatment for withdrawal seizures. Prophylaxis with benzodiazepines may be all that is required, although some authors advocate the use of phenytoin for 5 days, especially in persons with a history of prior seizures during alcohol withdrawal. Once established, delirium tremens are difficult to treat. Benzodiazepines are most commonly used to provide sedation, and extremely large doses may be required. Careful clinical assessment is essential to the proper treatment of patients undergoing alcohol withdrawal since the coexistence of medical problems may complicate the condition.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666958     DOI: 10.1002/j.1875-9114.1989.tb04119.x

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  7 in total

Review 1.  The drug management of severe alcohol withdrawal syndrome.

Authors:  M A Gillman; F J Lichtigfeld
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

2.  Dexmedetomidine for acute baclofen withdrawal.

Authors:  Simon Morr; Christopher M Heard; Veetai Li; Renée M Reynolds
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

3.  Benzodiazepines and Confusion in Medically Ill Alcoholics: Balancimg safety against toxicity.

Authors:  R L O'Reilly; D Smith
Journal:  Can Fam Physician       Date:  1991-12       Impact factor: 3.275

4.  Diagnosis and management of acute alcohol withdrawal.

Authors:  A M Holbrook; R Crowther; A Lotter; C Cheng; D King
Journal:  CMAJ       Date:  1999-03-09       Impact factor: 8.262

5.  Corticosterone increases severity of acute withdrawal from ethanol, pentobarbital, and diazepam in mice.

Authors:  A J Roberts; J C Crabbe; L D Keith
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

Review 6.  Life-threatening brain failure and agitation in the intensive care unit.

Authors:  D Crippen
Journal:  Crit Care       Date:  2000-03-21       Impact factor: 9.097

7.  Twenty-Eight-Day-Long Delirium Tremens.

Authors:  Paritosh Kafle; Amrendra Kumar Mandal; Binav Shrestha; Bikash Bhattrai; Manjul Bhandari; Shambhu Bhagat; Bijoy Shankar Kar; Dikshya Sharma; Vijay Gayam
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.